protocol IntroDuctIon
In recent years, zebrafish have emerged as an important and popular vertebrate model organism for studying gene function and as an alternative model system for understanding human diseases. However, one drawback that limits the utility of this model organism is the lack of technology to efficiently generate targeted mutations in genes of interest. Engineered zinc-finger nucleases (ZFNs) are broadly useful and powerful reagents for genome manipulation [1] [2] [3] [4] [5] [6] . These artificial proteins consist of a zinc-finger array fused to a non-specific nuclease domain 7, 8 . ZFNs have been used to direct double-strand DNA breaks (DSBs) to specific genomic loci and repair of these breaks by normal cellular repair machinery pathways often leads to the introduction of insertions and deletions (indels) at the site of the breaks [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . It has been shown that engineered ZFNs can induce targeted knockout mutations in cultured human cells and in a number of model organisms including zebrafish [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] . Engineering high-quality zinc-finger arrays is crucial to the generation of ZFNs that bind to their target sequences with high affinities and specificities 9, 17, 28, 29 . Engineered ZFNs bind as dimers to specific DNA sequences 7, 8, 30, 31 , and therefore two customized zinc-finger arrays must be engineered for each potential target site (Fig. 1) . We and others have shown that the zinc-finger arrays made by the selection-based Oligomerized Pool ENgineering (OPEN) can induce indel mutations at target genomic loci in zebrafish (as well as in plants and cultured human cells) with high efficiency 9, 17, 22, 26 . Alternatively, a process known as 'modular assembly' [32] [33] [34] [35] can also be used to assemble arrays from archives of individual, pre-selected zinc-finger domains 11, [19] [20] [21] 36 , although the efficiency of this process has been shown to be low 9, 37 . Reagents for engineering zinc-finger arrays by OPEN and modular assembly are publicly available from the plasmid distribution service Addgene (http://www.addgene. org) and detailed protocols for practicing OPEN 38 and modular assembly 39, 40 have been previously described. In addition, an online software program named ZiFiT (Zinc Finger Targeters, http:// www.zincfingers.org/software-tools.htm) can be used to identify potential ZFN target sites in any gene or sequence of interest 41 . The potential 'off-target' cleavage activities of engineered ZFNs have been investigated in two studies published by Doyon et al. and Meng et al. 16, 18 . In the first study, the authors were not able to detect any 'off-target' mutations at other genomic loci highly similar to the ZFN target site 16 . In the second study, the authors determined that engineered ZFNs are 770-fold more likely to introduce mutations at the ZFN target site than the other similar genomic loci in the embryos that developed normally after the injection of ZFN-encoding RNAs 18 . However, the off-target cleavages of engineered ZFNs often cause detrimental developmental defects in the embryos injected with ZFN-encoding RNAs [16] [17] [18] . It is conceivable that each pair of customized ZFNs will have different degrees of specificity (and toxicity) depending on the selected zinc-finger arrays. However, any potential collateral mutations in the founder can be removed by crossing the founder or outcrossing the heterozygous fish to wild-type fish.
There are several limitations to introducing targeted mutations using this method. First, a potential ZFN target site may not exist in the desired target regions of some of the zebrafish genes. Second, although all the OPEN-selected zinc-finger arrays should show satisfactory binding affinities to their target sequences in the bacterial two-hybrid (B2H) assays, some of the engineered ZFNs that use these arrays may fail to induce mutations in the target sites in vivo (see ANTICIPATED RESULTS). In addition, ZFNinduced mutations are random insertions or deletions. Thus, the exact mutations at the target sites cannot be predetermined using this method.
Here we provide a validated protocol for using engineered ZFNs to generate targeted mutations in endogenous zebrafish genes. This protocol is designed to seamlessly integrate with other protocols for engineering zinc-finger arrays by OPEN selection or modular 38, 40 .
To constitute a pair of functional ZFNs, DNA fragments encoding customized zinc-finger arrays are directly cloned into ZFN expression vectors designed to express engineered heterodimeric FokI nuclease domains 13, 42 ( Fig. 1) . To date, we have used this protocol to successfully identify ZFN-induced indel mutations in 12 endogenous zebrafish genes (ref. 17 and unpublished results). Starting with engineered zinc-finger arrays in hand, we can obtain homozygous zebrafish mutants in just six to seven months time. Our experience demonstrates that using customized ZFNs to introduce targeted mutations in endogenous zebrafish genes is rapid and robust. Figure 2 outlines the experimental procedures. First, DNA fragments encoding engineered zinc-finger arrays are cloned into plasmids previously described by the Zinc-Finger Consortium to create the ZFN expression vectors 38, 40 . Next, ZFNencoding RNAs are transcribed in vitro from these ZFN expression vectors and then introduced into early zebrafish embryos by microinjection. Subsequently, genomic DNA is isolated from a small number of the injected embryos and the somatic mutation efficiencies of the engineered ZFNs are assessed by sequencing. If ZFN-induced somatic mutations are detected with high frequency, the remaining injected embryos will be raised to adulthood and screened as potential founders. We describe below three different options for detecting ZFN-induced indel mutations in the progeny of potential founders depending on the resources available to individual laboratories and the sequences of targeted loci.
Experimental design A flowchart in
Direct sequencing. In this approach, PCR primers are designed to amplify approximately 500 bp of the genomic DNA sequence encompassing the expected mutation site. The resulting PCR product from each single embryo is subjected to sequencing using an internal primer residing inside the PCR fragment and at least 100-150 bp away from the ZFN target site. This approach can be used at any locus. However, the cost of this method is relatively higher than the other two options.
Fluorescent PCR analysis. In this method, PCR primers are designed to amplify ~150-350 bp of the genomic DNA sequence that flanks the expected mutation. One of the PCR primers is end-labelled with a fluorescent dye such as 6-FAM, NED, PET or VIC. The lengths of the labeled strand of the resulting PCR products are analyzed using an ABI 3730xl DNA analyzer. DNA strands from PCR products amplified from alleles that have sustained ZFN-induced indel mutations will be longer or shorter than those amplified from wild-type alleles. This method is also universal and fast. It is our preferred method because it is sensitive enough to identify indel mutations from small numbers of pooled embryos.
Restriction-digest analysis. In this method, the genomic DNA sequence surrounding the ZFN-cleavage site is analyzed to determine whether an indel mutation will destroy the recognition site of a restriction enzyme. If such a site can be identified, PCR products encompassing the ZFN-target site can be digested with the restriction enzyme and analyzed using gel electrophoresis. This method is only applicable to a subset of target sites that contain an appropriately placed restriction site. Step 38: Raise zebrafish embryos injected with ZFN-encoding RNAs to adulthood 2-3 months 
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In addition, in some cases, we have found insertional mutations that retain the recognition sequences of the test restriction enzymes because of the tendency of such mutations to duplicate regions of microhomology around the cleavage site during non-homologous end joining-mediated repair. However, this method is fast, inexpensive and does not require any specialized equipment.
As each pair of customized ZFNs will likely have a different degree of targeting efficiency in vivo, researchers that would like to conduct these experiments may wish to request existing zinc-finger arrays that have been deposited in the Zinc-Finger Database (ZiFDB; available at http://www. zincfingers.org/software-tools.htm) or published ZFNs to serve as controls [16] [17] [18] . 96-well 0.7 µm 2-ml polypropylene GF filter block (Seahorse Bioscience, cat. no. F20060) 1-ml 96-well polypropylene block (Nalgene Nunc, cat. no. 260252) EQUIPMENT Thermocycler Microcentrifuge, refrigerated and non-refrigerated Electrophoresis apparatus for acrylamide gels and/or agarose gels Microinjection apparatus (as previously described 43 ) Incubators at 37 °C and 28.5 °C Shaker incubator at 37 °C Sorvall RT6000D or other similar tabletop centrifuge ABI 3730xl DNA analyzer REAGENT SETUP Plasmid DNA encoding zinc-finger arrays Plasmid DNA encoding zinc-finger arrays were engineered using Zinc-Finger Consortium
MaterIals

REAGENTS
reagents for OPEN selection or modular assembly 38, 40 . These plasmids encode the engineered zinc-finger array between standardized XbaI and BamHI restriction sites built into the Consortium vectors. These plasmids also confer antibiotic resistance to carbenicillin. Plasmids encoding zinc-finger arrays selected by OPEN must be propagated in a bacterial strain encoding the lacI Q gene to prevent toxicity due to overexpression of the zinc fingers. Plasmids encoding zinc-finger arrays designed by modular assembly do not require propagation in any specialized E. coli strain. 10× BamHI buffer 1.5 M NaCl, 100 mM Tris-HCl, 100 mM MgCl 2 , 10 mM DTT, adjust pH to 7.9 using HCl; filter-sterilized. Store at − 20 °C for 1 year. 1× Danieau solution 58 mM NaCl, 0.7 mM KCl, 0.4 mM MgSO 4 , 0.6 mM Ca(NO 3 ) 2 , 5 mM HEPES, adjust pH to 7.6 using NaOH; filter-sterilized. Store at 25 °C for 1 year. Embryo water 5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl 2 , 0.33 mM MgSO 4 . Store at 25 °C for 1 month. Gene-specific primers Design primers for each ZFN-target site based on the genomic DNA sequence flanking it. Each primer should anneal about 150-250 bp away from the expected DSB location and extend toward it. Ideally, primers should have a melting temperature of ~65 °C and a length of 25 bp. Free online software such as Primer3 (http://frodo.wi.mit.edu/ primer3/) and OligoPerfect Designer (http://tools.invitrogen.com/content. cfm?pageid=9716) can be used for designing the primers. For fluorescent PCR analysis, one of the gene-specific primers must also be labeled with a fluorescent group on the 5′ end (e.g., 6-FAM, NED, PET or VIC). LB-carbenecillin agar plate Add 15 g agar into 1 liter of LB. Autoclave. Add 2 ml of 50 mg ml − 1 carbenecillin stock solution and pour into 40 10-cm petri dishes. Plates can be stored at 4 °C for upto 2 months. LB-carbenecillin medium Add 0.5 ml of 50 mg ml − 1 carbenecillin stock solution to 500 ml of autoclaved LB. Store at 4 °C for upto 2 months. LB-kanamycin agar plate Add 15 g agar into 1 liter of LB. Autoclave. Add 1 ml of 30 mg ml − 1 kanamycin stock solution and pour into 40 10-cm petri dishes. Store at 4 °C for upto 2 months. LB-kanamycin medium Add 0.5 ml of 30 mg ml − 1 kanamycin stock solution to 500 ml of autoclaved LB. Store at 4 °C for upto 2 months. TB-kanamycin medium Add 12 g bacto tryptone, 24 g bacto-yeast extract, 4 ml glycerol and H 2 O to 900 ml. Autoclave. Add 100 ml of a sterile solution of 0.17 M KH 2 PO 4 and 0.72 M K 2 HPO 4 and 1 ml of 30 mg ml − 1 kanamycin stock solution. Store at 4 °C for upto 2 months. Solution I 50 mM Tris, pH 8.0, 10 mM EDTA and 500 µg ml − 1 RNase A. Store at 4 °C for 1 year. Solution II 200 mM NaCl, 1% SDS (wt/vol). Store at 25 °C for 1 year. Solution III For 250 ml solution, add 58.88 g potassium acetate, 71.25 ml of glacial acetic acid and adjust pH to 4.8 using HCl. Store at 25 °C for 1 year. Acid-washed silica slurry made from Hyflo Super Cel Diatomaceous Earth Add 100 g Hyflo Super Cel Diatomaceous Earth to a 2-liter flask and then add sterile ddH 2 O to ~900 ml and then add 100 ml of HCl. Mix well and incubate overnight at 25 °C. Pour out the acid solution into a beaker (Note: this solution must be neutralized to pH 5.5-10.5 using NaOH before going down the drain). Refill the flask with 1 liter of H 2 O and let it settle for ~1 h. Pour off the supernatant containing fines. Repeat H 2 O rinses three additional times. Put a sterile stir bar into the flask and adjust the pH to 6-8 using NaOH. Allow to settle and pour off supernatant again. Resuspend in sterile ddH 2 O to a total of 500 ml. The silica should comprise ~40-50% of the volume. Store in a glass bottle at 25 3| Run 10 µl of the PCR product on a 5% non-denaturing polyacrylamide gel or a 3% agarose gel to verify successful amplification. The amplified PCR product should be ~300 bp. Purify the remainder of the PCR product using a QIAquick PCR purification kit, eluting the DNA with 50 µl of a 1:10 dilution of the supplied Buffer EB in nuclease-free water. 7| Purify the triple-digested DNA using a MinElute PCR purification kit by following the manufacturer's instructions except eluting the DNA with 10 µl of a 1:10 dilution of the Buffer EB (supplied in the kit) in nuclease-free water.
4|
8|
In parallel with the work of Steps 4-7, prepare the ZFN heterodimer vectors by digesting pMLM290 and pMLM292 with XbaI as tabulated below at 37 °C for 1 h. 10| Run the entirety of the reaction from Step 9 on a 5% polyacrylamide gel. Excise the 5.7-kb band. Elute the DNA from the cut gel piece as previously described 38 and resuspend the DNA pellet with 20 µl of nuclease-free water. (Alternatively, run the entirety of the reaction from Step 9 on a 1% agarose and purify the digested DNA using a QIAquick Gel Extraction kit.) 11| Ligate the purified PCR product from Step 7 and the purified vector backbone from Step 10 together as tabulated below, making sure to add the components in the order listed. Mix well and incubate the reaction at room temperature for 10 min.  crItIcal step pMLM290 and pMLM292 encode matched heterodimeric ZFN frameworks. Therefore, it is important to ensure that zinc-finger arrays for the two half-sites in each full ZFN target site are cloned into these vectors (i.e., make sure that each ZFN pair to be injected encodes one of each type of heterodimeric ZFN).  pause poInt Ligations can be frozen at − 20 °C indefinitely.
12|
Transform 200 µl of chemically competent XL-1 Blue cells with all of the ligation from Step 11 using standard transformation conditions as previously described 38 , and plate 1/3 of the transformation on an LB-carbenicillin agar plate. (Alternatively, transform commercially available high-efficiency competent cells.) Incubate the plate at 37 °C overnight. 15| Run 2 µl of the digestion mixture on a 1% agarose gel to confirm that the digestion is complete. Purify the linearized DNA using a QIAquick PCR purification kit, eluting the DNA with 50 µl of Buffer EB. Measure the concentration of the eluted DNA with a spectrophotometer.  pause poInt The eluted DNA can be stored at − 20 °C indefinitely.
16|
Transcribe ZFN-encoding RNA using an mMESSAGE mMACHINE T7 Ultra kit as tabulated below. Incubate the reaction mixture at 37 °C for 1 h.  crItIcal step The reaction mixture should be constituted in RNase-free microfuge tubes.
17| Add 1 µl of TURBO DNase provided in the kit to the reaction mixture and incubate at 37 °C for 15 min.
18| Carry out a poly(A) tailing reaction using the components provided in the kit as tabulated below. protocol band (sometimes multiple distinct bands due to secondary structures) without smearing. The RNA with a poly(A) tail should migrate more slowly on the gel (Fig. 3) . ? trouBlesHootInG 21| Add 25 µl of the Lithium Chloride Precipitation Solution provided in the kit to the reaction mixture. Mix well and incubate the samples at − 20 °C for 30 min.
22|
Centrifuge at 4 °C for 15 min at 14,000g. Discard the supernatant. Wash the pellet with 1 ml of 70% ethanol, and centrifuge again for 10 min.
23|
Completely remove the supernatant. Air-dry the pellet until it becomes transparent. Resuspend the pellet with 20 µl of nuclease-free water.
24|
Incubate the resuspended RNA samples at 65 °C for 10 min to dissolve the RNA. Measure RNA concentrations using a spectrophotometer. The total yield of the RNA should be around 15 µg. RNA should be stored at − 80 °C in 1-µl aliquots.  crItIcal step Preparation of aliquots is important because RNA degrades more readily if it is subjected to multiple freeze-thaw cycles.
Injection of ZFn-encoding rnas into zebrafish embryos • tIMInG ~2-3 d 25|
Set up zebrafish matings for spawning the evening before injection as described previously 44 .
26|
On the day of injection, set up for the injections of zebrafish embryos as described previously 43 . Prepare the injection solution as tabulated below. All components should be kept on ice.  crItIcal step Injection solution should be prepared fresh each time. Do not freeze the injection solutions and reuse.
27|
Centrifuge the injection solution at 14,000g for 5 min in a refrigerated microfuge. Load the injection solution into the capillary injection needle and inject ~2 nl of the solution into each zebrafish embryo.  crItIcal step It is important to inject the solution into the cell directly (not into the yolk) at the one-cell stage. The inclusion of phenol red in the injection solution is not essential but helps to monitor the location and the amount of solution injected. The volume of the injection can be measured using a micrometer slide 45 and should not exceed 1/10 of the cell's volume.
28|
Save some uninjected embryos as controls. Put the injected and uninjected embryos at 28.5 °C overnight. On the next day, remove and count the dead embryos. Divide the remaining embryos into two groups-normal-looking embryos and deformed embryos that show visible development defects (Fig. 4) . Count the numbers of embryos in each group. Remove deformed embryos and change the embryo water to prevent it from becoming spoiled. Place the normal-looking embryos back at 28.  pause poInt PCR product can be frozen at − 20 °C indefinitely.
33| Purify the PCR product using a MinElute PCR purification kit into 10 µl of a 1:10 dilution of Buffer EB (provided with the kit) in nuclease-free water.
34|
Subclone the PCR product into the pCR4 TOPO-TA vector using a TOPO-TA kit. Add 4 µl of the purified PCR product to 1 µl of the provided salt solution and 1 µl of the linearized pCR4 TOPO-TA vector, and incubate the mixture at 25 °C for 30 min.
Box 1 | ISoLATIoN oF GENoMIC DNA FRoM A PooL oF EMBRYoS FoR PCR
1. Place 6-12 embryos (2 and 3-d old) in a microfuge tube. Remove any liquid in the tube. 2. Add 500 µl of the SDS lysis buffer (10 mM Tris, pH 8.0, 200 mM NaCl, 10 mM EDTA, 0.5% SDS and 100 µg ml − 1 Proteinase K) and incubate at 50 °C for 2 h to overnight. 3. Invert the tubes a few times during the incubation to disperse the embryos. The lysis is complete when no clumps can be seen in the tube. 4 . Add 500 µl of 1:1 phenol-chloroform solution. Mix the solutions by inverting the tubes repeatedly for a minute. Spin the tubes in a microfuge at 14,000g for 5 min at room temperature. 5. Transfer the top layer of solution into a new tube and add 1 ml of 100% ethanol. Mix the solutions by inverting the tube a few times. Spin the tube at 4 °C at 14,000g for 20 min. 6. Remove the supernatant. Rinse the pellet with 1 ml of 70% ethanol and spin again at 4 °C at 14,000g for 10 min. 7. Remove the supernatant and air-dry the pellet. Resuspend the pellet with 40 µl of TE (10 mM Tris, pH 8, 0.5 mM EDTA).  crItIcal step The dried genomic DNA pellet takes time to go into the solution. Thus, after adding TE, flick the tube to dislodge the pellet. Let the DNA dissolve at room temperature for 2 h or at 4 °C overnight before setting up the PCR. Genomic DNA should be stored at 4 °C. 
36|
On the next day, pick 96 colonies from the transformation plate. Inoculate each single colony into 700 µl of TBkanamycin in a 2-ml 96-well pyramidal bottom block and incubate at 37 °C with agitation overnight. Isolate 96 plasmid DNA samples as described in Box 2 or using a commercially available kit. Sequence the DNA samples using the T3 sequencing primer supplied in the TOPO-TA kit.
37|
Align the sequencing results with the genomic DNA sequence encompassing the ZFN target site from Ensembl. Identify the clones that show evidence of ZFN-induced indel mutations. Calculate the somatic mutation rates of the engineered ZFNs using the following formula. Go to Step 38 if somatic mutations are detected.
Somatic mutation rates = # of clones with indel mutations/# of clones with PCR inserts. ? trouBlesHootInG Identify founders and the mutations transmitted through the founders • tIMInG ~2-3 months 38| Raise ~60 ZFN-injected embryos (Step 29) to adulthood to screen for founders. These fish are F0 and may be used for mating at 2-3 months of age. ? trouBlesHootInG 39| When F0 fish reach 2-3 months of age, set up matings between F0 and wild-type zebrafish. On the next day, collect each clutch of embryos in a petri dish. Put each F0 fish that has produced embryos into a single-housed tank. Label the F0 fish and its progeny embryos with matching numbers. (iv) Purify the PCR products using the QIAquick PCR purification kit. Elute each DNA using 50 µl of Buffer EB provided in the kit.
(v) Sequence the purified PCR products using an internal primer that is at least 100 bp upstream or downstream from the expected mutation. (vi) Compare the sequencing results to the genomic DNA sequence encompassing the ZFN-target site in Ensembl. If an embryo carries one wild-type and one mutant allele, the sequencing traces should be exactly the same as the sequence in Ensembl but become unreadable near the ZFN-target site because of simultaneous amplification of both alleles (Fig. 5) . Identify the F0 fish that transmit ZFN-induced mutations through the germline. If no founder is identified, repeat Steps 39-41 to screen more F0 zebrafish. The genomic DNA of the mutant embryo can be used in
Step 42 to obtain the sequence information of the exact mutation. Identify any restriction sites that lie in or overlap the spacer between the two ZFN half sites. Ideally these sites will not occur anywhere else in the region to be amplified by PCR. Using DNA analysis software, determine the sizes of fragments that will result from restriction digest of the PCR product from both the control embryo and embryos with indel mutations that destroy the restriction site. 
45|
Compare the sequencing results to the genomic DNA sequence in Ensembl to identify the exact mutation carried by each founder.
• Our experience has shown that the introduction of targeted mutations in endogenous zebrafish genes using engineered ZFNs is rapid and robust. We have successfully targeted 12 different endogenous zebrafish genes (as judged by the introduction of somatic mutations with frequencies ranging from 1% to 26%) (ref. 17 and unpublished results). To date, we have also successfully identified founders for all the five targeted loci that we have screened (5-50% founders in F0), even for one of the loci where the observed somatic mutation rate was only 6% (ref. 17 and unpublished results). The germline transmission rates of the identified founders range from 8% to 60% (ref. 17 and unpublished results). Although our mutagenesis frequencies are high, we note that some of the indels we have observed do not cause frameshift mutations. In this regard, one advantage of using the fluorescent PCR analysis approach to identify mutations is that the size differences of the mutant alleles may be determined and used to predict which founders are likely to carry frameshift mutations. All of the engineered zinc-finger arrays that we have used to construct ZFNs have demonstrated DNA-binding activities in B2H system. We do not know why some of the engineered ZFNs do not cause mutations in vivo. It is possible that some of the genomic loci may not be accessible because of the chromatin structure or modifications of the target DNA sites. If a pair of engineered ZFNs fails to introduce mutations in the target site, we recommend engineering ZFNs targeting other regions of the same gene. 
